Adaptive Biotechnologies Corp — Director's Dealing 2020

Aug 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adaptive Biotechnologies Corp (ADPT)
CIK: 0001478320
Period of Report: 2020-08-03

Reporting Person: HILL NANCY LOUISE (EVP, Operations & Program Mana)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-08-03	Common Stock	M	1600	$0.84	Acquired	11600	Direct
2020-08-03	Common Stock	S	1600	$37.37	Disposed	10000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-08-03	Stock Option (Right to Buy)	$0.84	M	1600	Disposed	2023-11-03	Common Stock (1600)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	500	Indirect
Common Stock	400	Indirect
Common Stock	300	Indirect

Footnotes

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2020.

F2: The reporting person disclaims beneficial ownership of these securities except to the extent of her pecuniary interest therein.

F3: The option is fully vested and exercisable.